AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...
Bayer gets approval for low-dose MRI contrast agent gadoquatrane in US: Berlin Tuesday, June 16, 2026, 12:00 Hrs [IST] Bayer has announced that the US Food and Drug Administration ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
ANNAPOLIS, MD, UNITED STATES, March 5, 2026 /EINPresswire.com/ — RadSite™, a leading accreditation agency promoting safety and quality in imaging, will host a ...
CHICAGO--(BUSINESS WIRE)--The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) today announced an educational partnership to help train sonographers to perform ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
This webinar will clarify who may administer contrast, what level of supervision is required, and how imaging suppliers can remain compliant while protecting patient safety.” — Eliot Siegel, MD, Chair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results